The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations

Evandro Mendes Klumb1, Morton Scheinberg2, Viviane Angelina de Souza3

  • 1Rheumatology Department, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, Brazil.

Lupus
|July 13, 2021
PubMed

Insights

Access to innovative diagnosis and treatment for systemic lupus erythematosus (SLE) and lupus nephritis (LN) in Brazil is limited. This review offers recommendations to overcome these barriers for public healthcare patients.

Area of Science:

  • Rheumatology
  • Nephrology
  • Public Health

Background:

  • Systemic lupus erythematosus (SLE) and lupus nephritis (LN) require timely diagnosis and treatment.
  • Patients in Brazil's public healthcare system face significant barriers to accessing innovative care.
  • Innovation adoption in healthcare is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify barriers to accessing SLE and LN diagnosis and treatment in Brazil's public healthcare system.
  • To develop recommendations for implementing innovative diagnostic tools and treatments for SLE/LN.
  • To address impediments to technology adoption in managing SLE/LN.

Main Methods:

  • A consensus-based approach was used, involving a panel of Brazilian SLE/LN experts.
  • Experts addressed key questions regarding access to care through a multi-day conference.
  • Responses were refined through multiple drafts and discussions to achieve group consensus.

Main Results:

  • Specific, realistic recommendations were proposed for implementing innovative diagnostic and treatment access for SLE/LN in Brazil.
  • The recommendations aim to overcome barriers and impediments to technology adoption.
  • Multidisciplinary care for SLE/LN necessitates stakeholder collaboration.

Conclusions:

  • There is a critical need to expand access to innovative diagnostic tools and treatments for SLE/LN globally, particularly in countries like Brazil.
  • The presented recommendations can guide new technology adoption strategies in similar healthcare settings.
  • Addressing access issues for SLE/LN is an urgent global health demand.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
46
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
147
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.7K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
73
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
954
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
208